ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.37 USD 1.48% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Capital Expenditures Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Capital Expenditures
-$590k
CAGR 3-Years
-114%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Capital Expenditures
-€2.8B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
Merck KGaA
XETRA:MRK
Capital Expenditures
-€2.2B
CAGR 3-Years
-11%
CAGR 5-Years
-16%
CAGR 10-Years
-16%
MPH Health Care AG
XETRA:93M1
Capital Expenditures
-€4.7k
CAGR 3-Years
-2%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Capital Expenditures
-€41.7m
CAGR 3-Years
5%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Capital Expenditures
-€866k
CAGR 3-Years
1%
CAGR 5-Years
-26%
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Capital Expenditures?
Capital Expenditures
-590k USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Capital Expenditures amounts to -590k USD.

What is ATAI Life Sciences NV's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-114%

Over the last year, the Capital Expenditures growth was 42%. The average annual Capital Expenditures growth rates for ATAI Life Sciences NV have been -114% over the past three years .

Back to Top